Pyrazinamide
- Generic Name
- Pyrazinamide
- Brand Names
- Rifater, Tebrazid
- Drug Type
- Small Molecule
- Chemical Formula
- C5H5N3O
- CAS Number
- 98-96-4
- Unique Ingredient Identifier
- 2KNI5N06TI
Overview
A pyrazine that is used therapeutically as an antitubercular agent.
Background
A pyrazine that is used therapeutically as an antitubercular agent.
Indication
For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
Associated Conditions
- Active Tuberculosis
- Pulmonary Tuberculosis (TB)
Clinical Trials
FDA Approved Products
Pyrazinamide
Manufacturer:Macleods Pharmaceuticals Limited
Route:ORAL
Strength:500 mg in 1 1
Approved: 2022/12/06
NDC:33342-447
Pyrazinamide
Manufacturer:REMEDYREPACK INC.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2024/03/01
NDC:70518-2534
Pyrazinamide
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:500 mg in 1 1
Approved: 2022/07/14
NDC:50090-0520
Pyrazinamide
Manufacturer:Novitium Pharma LLC
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/05/12
NDC:70954-484
Pyrazinamide
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/05/12
NDC:50090-5963
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath